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Abstract
Introduction: People with rheumatoid arthritis (RA) frequently suffer from compromised physical and psychological
health, however, little is known about positive indicators of health, due to a lack of validated outcome measures.
This study aims to validate a clinically relevant outcome measure of positive psychological well-being for people
with RA. The first study examined the reliability and factorial validity of the Subjective Vitality Scale (SVS), whilst
study 2 tested the instruments convergent validity.
Methods: In study 1, National Rheumatoid Arthritis Society members (N = 333; M age = 59.82 years SD = 11.00)
completed a postal questionnaire. For study 2, participants (N = 106; M age = 56 years, SD = 12 years) were those
recruited to a randomized control trial comparing two physical activity interventions who completed a range of
health-related questionnaires.
Results: The SVS had a high level of internal consistency (α = .93, Rho = .92). Confirmatory factor analysis supported
the uni-dimensional factor structure of the questionnaire among RA patients [χ = 1327 (10), CFI = 1.0, SRMSR = .01
and RMSEA = .00 (.00 - .08)]. Support for the scales convergent validity was revealed by significant (p < .05)
relationships, in expected directions, with health related quality of life (r = .59), physical function (r = .58), feelings of
fatigue (r = −.70), anxiety (r = −.57) and depression (r = −.73).
Conclusions: Results from two studies have provided support for the internal consistency, factorial structure and
convergent validity of the Subjective Vitality Scale. Researchers and healthcare providers may employ this clinically
relevant, freely available and brief assessment with the confidence that it is a valid and reliable measure of positive
psychological well-being for RA patients.
Trial registration: ClinicalTrials.gov ISRCTN04121489. Registered 5 September 2012.
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Introduction
Rheumatoid arthritis (RA) is the most prevalent chronic
inflammatory arthritis, characterized by periods of re-
mission and flares in disease activity unique to each indi-
vidual. Untreated, poorly controlled or active RA leads
to joint pain, stiffness, and swelling with eventual struc-
tural damage in affected joints [1]. In addition to these
symptoms, RA patients commonly experience life dissat-
isfaction and psychological distress. However, less is
known about positive indicators of well-being and posi-
tive functioning in RA patients, partly due to a lack of
validated psychometric instruments. This study aims to
fill this gap and provide evidence regarding the validity
and reliability of the Subjective Vitality Scale (SVS) as a
measure of positive psychological well-being for use with
RA patients.
Measuring psychological well-being
The psychological well-being of patients with RA is
frequently compromised [2] due to fluctuations in disease
activity; consequently, a body of research exists that inves-
tigates the physical concomitants of mental health and
physical function in this clinical population. The mental
health and psychological functioning of RA patients has
most frequently been operationalized through measures of
depression, anxiety and quality of life [2–5]. Research em-
phasis on anxiety and depression is not surprising given
the increased prevalence in RA patients [6]. Over 25 years
ago, Anderson and colleagues pointed to the high levels of
depression and anxiety in RA patients [7]. Therefore, it is
clear that anxiety and depression provide an important
indicator of the psychological distress that RA patients
experience.
However, psychological well-being does not simply refer
to an absence of negative pathologies, such as anxiety and
depression [8]. It is also important to consider the degree
to which positive psychological states are experienced.
Fewer studies have investigated the characteristics and
correlates of positive psychological well-being in RA [9].
Quality of life is frequently employed as a measure of psy-
chological well-being in patients with RA [10]. For ex-
ample, Treharne and colleagues [9] investigated the effects
of disease duration and psychosocial factors (i.e., social
support) on quality of life, assessed using the Quality of
Life Scale [11]. The Quality of Life Scale was developed
and validated for use among rheumatic patients, and mea-
sures participants’ subjective satisfaction with their quality
of life in 16 areas of importance (e.g., financial security
and health). Treharne and colleagues [9] revealed that
quality of life was highest in patients who had greater
levels of optimism, more social support and in those with
positive perceptions of the consequences of RA.
The Short Form 36 Health Survey (SF-36) [12] has
also been employed as a measure of quality of life in RA
patients [13, 14]. The SF-36 captures a variety of compo-
nents of positive functioning, including physical func-
tion, body pain, vitality, role limitations- physical, role
limitations- emotional general health, social function,
and mental health. Measures of positive and negative
affect have also been used as an assessment of psycho-
logical well-being in RA patients [2, 15, 16]. Coty and
Wallston [2] showed that women with RA had lower
levels of positive affect, compared to healthy women.
Although measures of quality of life and positive affect
can be considered positive indicators of well-being, con-
temporary conceptualizations suggest that these facets
center on more hedonic aspects of well-being (i.e., pleasure
or happiness) and fail to adequately capture eudaimonic
well-being [8]. When individuals experience eudaimonia,
they experience optimal functioning. For example, success-
ful treatment of the physical symptoms of RA may help to
increase quality of life and have people in a better mood
(e.g., stemming from their enhanced physical function) but
the impact of the treatment on one’s overall psychological
health and functioning may not be optimized [10]. There-
fore, the vitality subscale of the SF-36 is grounded in a
measure of hedonic well-being. In contrast, the Subjective
Vitality Scale was specifically developed as a measure of
eudaimonic well-being and explicitly captures qualities
such as energy and spirit.
Subjective vitality
Subjective vitality is an indicator of eudaimonic well-
being that appears particularly salient for RA patients.
Conceptualized as a specific and subjective positive psy-
chological state, subjective vitality has been defined as a
sense of feeling alive, vital, and full of energy [17]. This
definition of subjective vitality aligns with the World
Health Organization’s definition of psychological well-
being as ‘a state of well-being in which every individual
realizes his or her own potential, can cope with the nor-
mal stress of life, and can work productively and effect-
ively’ [18]. Ryan and Frederick [17] further defined
subjective vitality as energy that is perceived to emanate
from the self, with an internal locus of causality and is
influenced by both psychological and physical factors. It
is an individual’s own appraisal of those factors that de-
termine the degree of energy and spirit felt. For example,
pain caused by RA, would interfere with one’s feelings of
energy; however, the perceived meaning behind the
physical symptom will determine the strength of vitality
experienced. Therefore, subjective vitality appears to be
a relevant measure of subjectively experienced positive
psychological well-being that could provide additional
information regarding the influence of RA on an individ-
ual’s overall physical and psychological functioning. Val-
idating the SVS [17] could clarify the contribution of
psychological well-being to the buffering role in coping
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with stress, the positive effect of interventions on disease
course, and serve as an indicator of those vulnerable to
depression [19].
The SVS was developed by Ryan and Frederick [17] in
response to the lack of scientific investigation into opti-
mal (in contrast to compromised) psychological func-
tioning and has been validated and used as a measure of
psychological well-being in a range of populations, in-
cluding adult smokers, athletes, dancers, and university
students [20–22]. However, to our knowledge no single
scale assessing reported vitality (such as the SVS) has
been validated for use with RA patients. The SVS was
also selected for validation as it is freely available to use
without payment or the need to request permission, in-
creasing access and availability.
Study aims
In order to ascertain whether the SVS is valid for use
with RA patients, it is necessary to establish that all the
items measure the same construct and that it is measur-
ing what it is intended to measure, a state of positive
psychological well-being. Study 1, therefore, tests the
internal consistency of the scale by examining the
Cronbach alphas and factorial validity through structural
equation modeling. Study 2 assesses the construct valid-
ity of the SVS by testing the scale’s convergent validity.
It is hypothesized that scores on the subjective vitality
scale will demonstrate a positive correlation with other
indicators of positive well-being and a negative relation-
ship with indicators of compromised well-being/ill-being.
Therefore, Study 2 examines the correlations between
scores on the SVS with measures of physical function,
quality of life, depression, anxiety, and fatigue.
Methods
Study 1 Methods
Members of the National Rheumatoid Arthritis Society
(UK) were sent a pack containing an information sheet,
consent form, questionnaire and a pre-paid stamped ad-
dressed envelope. Three hundred and thirty three (76 men
and 256 women) participants returned the questionnaire
and written informed consent forms (66 % return rate).
Participants were middle aged (average age = 59.82 years
SD = 11.00), predominantly white (96 %), married (68 %)
and female (77 %). All participants had been diagnosed
with RA (average duration = 14.80 years, SD = 11.34).
Ethical approval was obtained from the National Health
Services, Birmingham, East, North and Solihull Research
Ethics Committee (10/H1206/59) ethics committee.
Measures
The five item version of the Subjective Vitality Scale
(SVS) [17, 22] was employed as a positive indicator of
mental health and well-being in patients with RA.
Participants responded to how they felt over the last two
weeks, using a scale anchored by 1 (not at all true) to 7
(very true). See Table 1 for all questionnaire items. The
SVS has shown good internal consistency in past work
in the general population with Cronbach alphas ranging
from 0.84 - 0.86 [22].
Data analyses
Cronbach alphas were used to establish the internal
consistency of the scale. An alpha ≥ .70 was considered
to meet acceptable consistency. Given the debate regard-
ing the dependability of Cronbach alpha as an estimator
of reliability [23], Raykov’s Rho index was also employed.
Raykov’s Rho index [24] provides an alternative measure
of reliability for unidimensional scales that was devel-
oped for latent variable modelling [23]. Confirmatory
factor analysis, employing the software package EQS 6.1
was conducted to examine the single factor structure of
the Subjective Vitality Scale. The comparative fit index
(CFI), standardized root mean square residual (SRMSR)
and root mean square error of approximation (RMSEA)
were used to determine overall model fit. As proposed
by Hu and Bentler [25], a model demonstrates good fit
when the CFI is ≥ .95, the SRMR is ≤ .08 and the RMSEA
is ≤ .06. Questionnaire items with loadings ≥ .4 are con-
sidered to be representative of the construct; however,
loadings ≥ .63 are considered very good [26].
Study 1 Results
Descriptive statistics revealed that the mean subjective
vitality score was moderate to low (M = 3.65 SD = 1.49)
with 7 being the highest score. The SVS revealed a good
level of internal consistency (α = .93, Rho = .92) and
Mardia’s normalized estimate of multivariate kurtosis
was 7.75. Scores on Mardia’s coefficient that are greater
Table 1 Overall model fit and factors loadings for the
Subjective Vitality Scale in patients with rheumatoid arthritis
Subjective Vitality Scale items Factor loadings
I feel alive and full of vitality .93
I have energy and spirit. .90
I look forward to each day .68
I nearly always feel alert and awake .84
I feel I have a lot of energy .89
Model Fit
χ 1327 (10)
S-B Chi-square 29.56 (5)
CFI 1.0
SRMSR .01
RMSEA .00 (.00 -.08)
S-B Satorra-Bentler, CFI Comparative fit index, SRMSR standardized root mean
square residual, RMSEA root mean square error of approximation
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than 7 were initially thought to represent data with a
multivariate non-normal distribution [27]; however,
Bentler [28] later suggested a more robust cut-off (>5).
The multivariate distribution of the present data does
not meet these recommendations indicating the
multivariate distribution is non-normal. Therefore, the
Satorra-Bentler (S-B) chi-square test will be employed as it
is the most robust test statistic with data that are multi-
variate non-normal. The S-B chi-square test incorporates a
scaling correction that considers the model, estimation
method and kurtosis values, thereby producing a more
trustworthy fit index [29]. Confirmatory factor analysis
demonstrated a good fit to the single factor questionnaire
in patients with RA (Satorra-Bentler chi-square = 29.56 (5),
CFI = .98, SRMR= .03 and RMSEA= .13 CI = .08 - .17).
The standardized loadings ranged from .68 - .93 (See
Table 1 for all standardized loadings).
Study 2 Methods
For Study 2, participants were enrolled in a randomized
controlled trial [ISRCTN04121489] investigating the ef-
fects of physical activity on cardio-respiratory fitness
[30]. Ethical approval was obtained from the National
Health Services, Birmingham, East, North and Solihull
Research Ethics Committee (10/H1206/59). Data were
used from the baseline assessment point. All participants
provided written informed consent prior to participating
in the study. Participants (N = 106) were predominantly
married (66 %), middle aged (M age = 54.5 years, SD =
12.3 years), and female (68 %), with only 31 % employed.
On average, disease duration was 7.4 years (SD =
8.6 years).
Measures
In addition to the Subjective Vitality Scale, the following
measures were completed by study participants:
Physical function
The Anglicized version of the 40 item Stanford Health
Assessment Questionnaire (HAQ) [31] was used to assess
patients’ physical function. Participants rated their ability
(over the past week) to carry out 20 activities within eight
aspects of daily living (dressing/grooming, rising, eating,
walking, hygiene, reach, grip, and errands/tasks) on a four
point scale from ‘without any difficulty’ to ‘unable to do’.
For each aspect participants also responded to whether
they receive assistance from people or use specific devices.
The HAQ has been shown to possess high levels of in-
ternal consistency (α = .94) in patients with RA [32].
Quality of life
The EuroQol [33] self-assesses health related quality of
life across five domains: mobility, self-care, usual activ-
ities, pain, discomfort and depression/anxiety. Each item
has three levels of severity: ‘no problems’, ‘some prob-
lems’ and ‘severe problems’. The EQ-5D has previously
been employed as a measure of health related quality of
life in patients with RA [34].
Anxiety and depression
The Hospital Anxiety and Depression Scale (HADS) [35]
measures participants’ depressive and anxiety symptoms.
The HADS consists of 14 items (seven each for anxiety
and depression) rated on different four point scoring
systems. The subscales are internally consistent (α = .85
and .78, respectively) and have demonstrated convergent
validity in the case of RA patients [9].
Fatigue
The 16-item Multidimensional Assessment of Fatigue
(MAF) measures four dimensions: severity, distress, de-
gree of interference in activities of daily living, and tim-
ing. Participants are asked to rate to what degree fatigue
interferes with fourteen items, such as household chores,
on a scale from 1 “not at all” to 10 “a great deal”. Two
additional items have multiple-choice responses [36].
Participants were asked to reflect on fatigue patterns for
the past week.
Results
RA patients recruited to an exercise intervention experi-
enced feelings of vitality (mean 4.01 SD = 1.55), fatigue
(25.94 SD = 11.96), quality of life (0.67 SD = 0.24), phys-
ical function (0.52 SD = 0.49), low levels of anxiety (6.85
SD = 4.28), and depression (4.85 SD = 3.47). Pearson cor-
relation coefficients revealed that the SVS was signifi-
cantly and positively related to health related quality of
life and physical function. Conversely feelings of subject-
ive vitality were significantly and negatively related to
feelings of fatigue, anxiety, and depression (see Table 2).
Discussion
Currently, a limited number of validated measures of posi-
tive psychological well-being exist for patients with
rheumatoid arthritis (RA) contributing to a heavy reliance
Table 2 Pearson correlation coefficients between subjective
vitality and measures of well-being in patients with rheumatoid
arthritis from Study 2
Measures Subjective Vitality
Mean SD r
Subjective vitality 4.05 1.57
Quality of life .68 .24 .59
Physical function .51 .48 .58
Global fatigue 26.0 11.79 -.70
Anxiety 6.78 4.24 -.53
Depression 4.82 3.48 -.73
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on negative indicators of well-being (such as anxiety and
depression) in this clinical population. The purpose of this
paper was to validate the SVS as a brief, freely available
measure of positive psychological well-being in RA pa-
tients so that it can be used for both clinical and research
purposes. The SVS appears to be a particularly relevant
measure as it targets what is typically examined and coun-
ters the negative symptoms patients with RA experience
(e.g., lack of energy).
Construct validity
The aim of the current study was to assess the internal
consistency and construct validity of the SVS for pa-
tients with RA. Study 1 provides support for the internal
consistency of the SVS. High Cronbach alpha and
Raykov’s rho scores demonstrate that the way patients
with RA rated the five different items corresponded to
each other. Similar to other populations, such as univer-
sity students [22], patients with RA appear to have
understood the meaning behind each item. This finding
suggests that the amount of random error generated by
the SVS in RA patients due to guessing or misunder-
standing is low [22]. Study 1 also provided support for
the factorial validity of the SVS through confirmatory
factor analysis. Data collected from predominantly fe-
male middle aged members of NRAS demonstrated a
good fit to the single factor structure of the question-
naire as recommended by the most commonly employed
criteria proposed by Hu and Bentler [25]. However, it is
noteworthy that although the CFI, Chi-square, and
SRMSR highlight a good fit, the RMSEA failed to meet
the recommended cut-off of ≤ .08. This inconsistency
may be explained by the small number of variables
(items) that are included in the CFA. The RMSEA is
expressed per degree of freedom and is, therefore, sensi-
tive to the number of estimated parameters in the model
[29]. Kenny and McCoach [37] highlight that the
RMSEA tends to improve as the number of the variables
included within the model increases.
Patient profile
Results from Study 1 indicated that RA patients scored
moderate to low on feelings of subjective vitality. Mean
scores from participants in Study 2 were slightly higher.
The elevated score found in Study 2 could be explained by
the fact that participants were RA patients who had signed
up to participate in an exercise intervention. Therefore,
we could surmise that participants from Study 2 felt that
they possessed sufficient energy to engage in physical ac-
tivity. It is noteworthy, however, that subjective vitality
scores from both studies are suppressed compared to
healthy populations. Vlachopoulos and Karavani [38] in-
vestigated perceptions of subjective vitality in 388 healthy
exercisers between 18- and 61-years old and found a mean
score of 4.96 (SD = 1.36). Due to a lack of previous re-
search employing the SVS in RA, it is not possible to draw
direct comparison with RA patients’ scores from other
studies. However, some measures of health related quality
of life include a vitality dimension (e.g., SF-36) and studies
that have used these measures indicate that RA patients
score just over midway on the scale whereas the general
population scored higher [39]. Therefore, scores on the
SVS employed in the present studies appear to replicate
and support those generated from vitality subscales taken
from measures of quality of life in RA patients.
Convergent validity
Study 2 provided support for the convergent validity of
the SVS through significant positive correlations with in-
dicators of well-being and enhanced functioning. Higher
scores on the SVS were associated with higher scores for
health related quality of life, one of the most frequently
employed measures of positive well-being in RA [10].
Therefore, if an RA patient feels full of energy and alive
they are also more likely to perceive that they have a bet-
ter quality of life. Participants who perceived themselves
to be experiencing high levels of vitality were also more
likely to report that they have better physical function.
However, previous research suggests that physical im-
pairment does not necessarily denote poor psychological
well-being [10]. Ryan and Frederick [17] also indicate
that it is the individual’s appraisal of the impairment that
determines the consequence for feelings of subjective vi-
tality. RA is characterized by periods of flares and remis-
sion; therefore, it would be important for future research
to investigate whether feelings of subjective vitality can
persist in the context of pain and decreased physical
functioning caused by flares in disease activity.
Significant medium to strong negative relationships
were revealed between the SVS and measures of com-
promised well-being/ill-being. A strong negative rela-
tionship was shown between SVS and perceptions of
fatigue supporting the hypothesized inverse relationship
between the positive and negative indicators of well-
being. This finding replicates previous research in RA
patients indicating that feelings of vitality (SF-36) are
strongly and negatively associated with patients’ experi-
ence of fatigue [39, 40]. Medium to strong negative
correlations with anxiety and depression were also re-
vealed demonstrating that patients with RA who re-
ported higher levels of subjective vitality report fewer
indications of diminished mental health. The significant
association observed between subjective vitality and de-
pressive symptoms replicates and extends findings from
previous research in other populations, such as adoles-
cents [41]. Therefore, correlation analyses from Study 2
support the use of the SVS as a positive indicator of psy-
chological well-being in patients with RA.
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Clinical relevance and future research
The SVS was selected for validation as it was systematic-
ally developed as a measure of eudaimonic well-being that
can be meaningfully integrated into theories of human
functioning [17]. In contrast, the other available measure
is a subscale from the SF-36 that is designed to measure
quality of life. Important philosophical differences in the
conceptualization of well-being distinguish these two in-
struments and highlight the importance of validating the
SVS for patients with RA. Inspection of the SVS also re-
veals that only items pertaining to feelings of energy and
aliveness are included, whereas, the SF-36 includes items
relating to fatigue and weakness that could be confounded
by negative states, such as depression, fatigue and other
health related symptoms [17].
The SVS can provide clinically relevant data on patients’
positive psychological well-being that is not currently gath-
ered due to the lack of validated instruments. Reid and
colleagues [42] highlight the utility and contribution of self-
reports of subjective well-being in identifying individuals at
risk of adverse health outcomes. Subjective well-being can
also provide an additional criterion for examining the ef-
fectiveness of treatment programs. Quantitative data from
the SVS would allow clinicians and rheumatology health-
care providers to track and assess the positive (rather than
negative) psychological responses of RA patients to treat-
ment. However, a psychometric instrument can only have
clinical relevance if it can be feasibly administered, scored,
and interpreted by the relevant parties. The SVS is a short
five item questionnaire that RA patients would find easy to
answer and complete with rheumatology healthcare pro-
viders able to score and interpret data quickly. Thus, we
would suggest that the five item SVS is feasible to use in
clinical practice. Future research can also employ the SVS
to examine and test the effect of interventions, both behav-
ioral and cognitive, on an indicator of positive psycho-
logical well-being in RA patients. The SVS can be used as a
primary or secondary outcome with the confidence that it
measures a positive indicator of well-being and optimal
functioning for this population.
Despite the support provided in the present research
for the use of the SVS with RA patients, it is important
to highlight that this validation is somewhat limited by
the predominantly female and middle aged sample that
the data represent. However, RA is more prominent in
women and most frequently but not always diagnosed in
middle aged patients. The validity of the SVS may be
further tested by examining whether the factor structure
is invariant across gender and other RA characteristics,
such as disease duration or severity.
Conclusions
This study offers support for the internal consistency,
construct and convergent validity of the SVS as a
positive indicator of psychological well-being in patients
with RA. Researchers and rheumatology healthcare pro-
viders may employ this clinically relevant, freely available
and feasible instrument with the confidence that it is a
valid measure of optimal function and well-being. Future
research studies may also employ this measure to facilitate
understanding of the potential mechanisms that underpin
the positive psychological well-being in RA patients.
Significance and innovations
 The mental health and psychological functioning of
RA patients has most frequently been
operationalized through measures of compromised
health, such as depression and anxiety.
 Little is known about positive indicators of well-
being and positive functioning in RA patients, partly
due to a lack of validated outcome measures.
 Scores from the Subjective Vitality Scale correlated
with indicators of both physical and psychological
functioning in patients with RA.
 Researchers and rheumatology healthcare providers
may employ the Subjective Vitality Scale as a
clinically relevant and feasible outcome measure
with the confidence that it is a valid measure of
positive health and well-being.
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